Anticancer Activity and Molecular Docking Studies of Selected Benzoxazole Derivatives as Apoptosis Inducers in Non-Small Cell Lung Cancer
| dc.contributor.author | Baba, Burcu | |
| dc.contributor.author | Kopru, Cagla Zubeyde | |
| dc.contributor.author | Yildiz, Ilkay | |
| dc.contributor.author | Yardimci, Elif | |
| dc.contributor.author | Akbay, Aysegul | |
| dc.date.accessioned | 2026-10-09T21:51:17Z | |
| dc.date.issued | 2026 | |
| dc.department | Yüksek İhtisas Üniversitesi | |
| dc.description.abstract | Objective: Non-small cell lung cancer (NSCLC), the most prevalent type of lung cancer, remains the leading cause of cancer-related deaths worldwide. Late-stage diagnosis and resistance to conventional treatments highlight the need for further research into its molecular mechanisms. This study aimed to evaluate the anticancer effects of several benzoxazole derivatives (2-(4-tert-butylphenyl)-5-nitrobenzoxazole (1a), 2-(4-tert-butylphenyl)-6-nitrobenzoxazole (1b), 2-(2,3-dimethylphenyl)-5-nitrobenzoxazole (2a), and 2-(2,3-dimethylphenyl)-6-nitrobenzoxazole (2b)) on the viability of A549 cells. Materials and Methods: Cell viability was assessed using the MTT assay. We also performed a molecular docking study to investigate the interactions between the benzoxazole derivatives and caspase-3, a key executioner caspase involved in apoptosis. Results: The benzoxazole derivatives coded 1a, 1b, 2a, and 2b exhibited anticancer activity against A549 cells, with half-maximal inhibitory concentration (IC50) values of 17.41 +/- 0.16, 20.50 +/- 0.08, 32.17 +/- 0.08, and 31.13 +/- 0.07 & micro;M, respectively. Among the tested benzoxazoles, 1a and 1b showed activity comparable to cisplatin (IC50=19.65 +/- 0.09 & micro;M). According to the docking results, all compounds demonstrated satisfactory docking scores ranging from-4.339 to-5.202 kcal/mol. Conclusion: Our results demonstrate that the benzoxazole derivatives 1a and 1b exhibit significant anticancer effects by inhibiting lung cancer cell proliferation at low concentrations, similar to cisplatin. The structure-activity relationship suggests that substitution of a phenyl group at the 2-position of the benzoxazole ring with a tert-butyl group at the para position enhances anticancer activity against A549 cells. This preliminary study indicates that these benzoxazole derivatives have promising potential as cytotoxic agents for the treatment of | |
| dc.identifier.doi | 10.14744/cpr.2026.53706 | |
| dc.identifier.issn | 2980-2156 | |
| dc.identifier.issue | 1 | |
| dc.identifier.uri | https://doi.org/10.14744/cpr.2026.53706 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12794/3816 | |
| dc.identifier.volume | 48 | |
| dc.identifier.wos | WOS:001717094100007 | |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak.diger | Emerging Sources Citation Index (ESCI) | |
| dc.language.iso | en | |
| dc.publisher | Erciyes Univ Sch Medicine | |
| dc.relation.ispartof | Journal of Clinical Practice and Research | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.relation.sdg | Goal-03: Good Health and Well-Being | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WoS_20260922 | |
| dc.subject | Apoptosis | |
| dc.subject | Benzoxazole | |
| dc.subject | Cancer | |
| dc.subject | Molecular Docking | |
| dc.subject | Non-Small Cell Lung Cancer | |
| dc.title | Anticancer Activity and Molecular Docking Studies of Selected Benzoxazole Derivatives as Apoptosis Inducers in Non-Small Cell Lung Cancer | |
| dc.type | Article |







